
Pacific Biosciences of California, Inc. (PACB)
Pacific Biosciences of California, Inc. does not pay dividends currently đ
They might in the future, check back soon!
About Pacific Biosciences of California, Inc.
Pacific Biosciences of California, Inc., often referred to as PacBio, is a biotechnology company specializing in advanced DNA sequencing technologies. Founded in 2004 and headquartered in Menlo Park, California, PacBio is renowned for its development of single-molecule, real-time (SMRT) sequencing. This technology provides highly accurate, long-read genomic data, which is crucial for various applications in research, clinical diagnostics, and agriculture. As of the latest updates, Christian Henry serves as the CEO, having taken the helm to drive innovation and expansion. PacBio has made significant strides in sequencing technology, emphasizing the importance of understanding genetic variations and their implications in health and disease. The company has positioned itself as a leader in the life sciences sector, serving a wide range of industries with its cutting-edge solutions. Financially, PacBio has seen substantial growth in revenue, reflecting the increasing demand for its pioneering technologies. Their contributions to genomics continue to impact scientific discovery and personalized medicine significantly.